RE:RE:Bracelet OS"My suspicion is that there were industry doubts around IND-213 results; no-one would pony up the cost of the Phase III - remember. all they had to do was re-run IND-213. If they believed in the data so much, then they should have run it... AND it would be finished by now. "
FFS, Quentin, I gave you a completely accurate and reasonable reply when you raised this same BS comment last week!
The FDA told them not to do it! They said you should get a biomarker and other evidence of an immune response instead of just doing the same trial.
Of course BP did not want to pay for a trial on that basis.
Instead they partnered with Pfizer to run some confirmatory trials, look for biomarkers and get evidence on the TME.
That is not hard to understand!
Why people prevaricate and complain on the internet about this company is beyond me.
YOU bought the stock. YOU continue to hold it. YOU could sell tomorrow but instead you would rather complain like Ionc.